WOW! This is amazing news for us all with genetic sight loss conditions and it looks hopeful.
Told you I was going to get away with it!
Now, let me not get ahead of myself.
That’s if I’ve actually got Stargardts Disease. I was just diagnosed with Macular Dystrophy which Stargardts is within that spectrum and the likely possibility as it is the most common form.
Must ask about genetic testing when I eventually see that consultant I’m still waiting to see for all my results. Which will be obsolete now.
The drug, known as LBS-008, is an orally administered tablet and has been trialled in patients over a 12-month period, as part of a phase two clinical study by US-based pharmaceutical company, Belite Bio.
It is hoped the tablet, which is now in phase three trials, will halt or slow the progression of Stargardt, one of the most common forms of inherited macular disease, which there is currently no treatment for.
Hopefully, if this works it may unlock the key to curing or treating the many other forms of Macular Dystrophy.
Read more below in the Macular Societys Facebook link.
Macular Society facebook page to read more.
Or, click link below for the original article.
Click here to read on Macular Society website
❤️ 🙏
One Vision Blog 